| | 204326-43-2 Basic information More.. |
| Product Name: | NS-2028 | | Synonyms: | NS-2028;8-BROMO-4H-2,5-DIOXA-3,9B-DIAZA CYCLOPENTA[A]NAPHTHALEN-1-ONE;4H-8-BROMO-1,2,4-OXADIAZOLO(3,4-D)BENZ(B)(1,4)OXAZIN-1-ONE;4H-8-BROMO-1,2,4-OXADIAZOLO(3,4-D)BENZO(B)(1,4)OXAZIN-1-ONE;4-H-BROMO-1,2,4-OXADIAZOLE(3,4-ALPHA)BENZ(B)OXAZIN-1-ONE;NS 2028 - CAS 204326-43-2 - Calbiochem;8-Bromo-1H,4H-[1,2,4]Oxadiazolo[3,4-c][1,4]Benzoxazin-1-One;8-bromo-4~{H}-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one | | CAS: | 204326-43-2 | | MF: | C9H5BrN2O3 | | MW: | 269.05 | | EINECS: | | | Mol File: | 204326-43-2.mol |  |
Use
NS-2028 potent soluble guanylyl cyclase (sGC) inhibitor (Ki = 8 nM). NS-2028 blocks sGC activity in murine cerebellum induced by S-nitroso-glutathione and NMDA. NS-2028 inhibits VEGF-induced cGMP accumulation; abolishes VEGF-induced migration in postcapillary venular endothelial cells (CVEC).
- NS-2028
-
- US $55.00-243.00 / mg
- 2024-11-14
- CAS:204326-43-2
- Min. Order:
- Purity: 99.44%
- Supply Ability: 10g
- NS-2028
-
- US $1.00 / KG
- 2020-01-19
- CAS:204326-43-2
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 100kg
|
|
204326-43-2
Recommend Suppliers |
|